TYRA News and Press, Tyra Biosciences Inc.

2026-07-01 07:26:56 ET Read the full article on Seeking Alpha For further details see: William Blair updates conviction list: Oracle in, Meta out and more

TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY PR Newswire -Collaboration aims to raise awareness of UTUC and the need for continued innovation for patients living with this rare and difficult-to-treat cancer- CARLSBAD, Calif. , ...

2026-05-19 07:15:04 ET Wolfe Research analyst issues PEER PERFORM recommendation for TYRA on May 19, 2026 10:07AM ET. TYRA was trading at $35.66 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 7 - Buy rec...

2026-05-17 15:01:48 ET On May 15, 2026, HighVista Strategies disclosed a purchase of 96,218 shares of Tyra Biosciences (NASDAQ:TYRA) , estimated at $3.11 million based on quarterly average pricing. According to its SEC filing dated May 15, 2026, HighVista Strategies increase...

2026-05-13 17:20:44 ET Tyra Biosciences, Inc. (TYRA) Bank of America Global Healthcare Conference 2026 May 13, 2026 1:40 PM EDT... Read the full article on Seeking Alpha For further details see: Tyra Biosciences, Inc. (TYRA) Presents at Bank of America Global Healthcare Conf...

2026-05-13 09:41:03 ET More on Tyra Biosciences Seeking Alpha’s Quant Rating on Tyra Biosciences Historical earnings data for Tyra Biosciences Financial information for Tyra Biosciences Read the full article on Seeking Alpha For further details...

Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights PR Newswire - Advanced " dabogratinib 3x3 "  strategy to pursue 3 late-stage clinical studies in LG-UTUC, IR NMIBC and ACH - - First LG-UTUC patient dosed with dabogratinib in SURF303; init...

2026-05-12 11:01:17 ET Read the full article on Seeking Alpha For further details see: Healthcare stocks with A+ momentum investors are watching

Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors PR Newswire - Seasoned biopharmaceutical leader brings deep commercial and strategic expertise to support TYRA's next phase of growth- CARLSBAD, Calif. , April 17, 2026 /PRNewswire/ -- Tyra Biosci...

2026-04-14 18:02:11 ET Brad Canino from Guggenheim issued a price target of $54.00 for TYRA on 2026-04-14 20:14:45. The adjusted price target was set to $54.00. At the time of the announcement, TYRA was trading at $35.27. The overall price target consensus is at $49.80 w...